Steven A Shallcross - Net Worth and Insider Trading
Steven A Shallcross Net Worth
The estimated net worth of Steven A Shallcross is at least $14,400 dollars as of 2024-12-27. Steven A Shallcross is the CEO and CFO of Theriva Biologics Inc and owns about 10,000 shares of Theriva Biologics Inc (TOVX) stock worth over $14,400. Details can be seen in Steven A Shallcross's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Steven A Shallcross has not made any transactions after 2023-06-07 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Steven A Shallcross
Steven A Shallcross Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Steven A Shallcross owns 5 companies in total, including Elys Bmg Group Inc (ELYS) , Theriva Biologics Inc (TOVX) , and Nuo Therapeutics Inc (AURX) among others .
Click here to see the complete history of Steven A Shallcross’s form 4 insider trades.
Insider Ownership Summary of Steven A Shallcross
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ELYS | Elys Bmg Group Inc | 2019-06-13 | director |
| TOVX | Theriva Biologics Inc | 2023-06-07 | director & CEO and CFO |
| AURX | Nuo Therapeutics Inc | 2013-03-30 | SEE REMARKS |
 | | 2006-04-12 | Sr. VP & CFO & Treasurer |
| | 2021-07-20 | director |
Steven A Shallcross Latest Holdings Summary
Steven A Shallcross currently owns a total of 1 stock. Steven A Shallcross owns 10,000 shares of Theriva Biologics Inc (TOVX) as of June 7, 2023, with a value of $14,400.
Latest Holdings of Steven A Shallcross
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TOVX | Theriva Biologics Inc | 2023-06-07 | 10,000 | 1.44 | 14,400 |
Holding Weightings of Steven A Shallcross
Steven A Shallcross Form 4 Trading Tracker
According to the SEC Form 4 filings, Steven A Shallcross has made a total of 7 transactions in Theriva Biologics Inc (TOVX) over the past 5 years, including 7 buys and 0 sells. The most-recent trade in Theriva Biologics Inc is the acquisition of 560 shares on June 7, 2023, which cost Steven A Shallcross around $9,660.
Insider Trading History of Steven A Shallcross
- 1
Steven A Shallcross Trading Performance
GuruFocus tracks the stock performance after each of Steven A Shallcross's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven A Shallcross is -10.69%. GuruFocus also compares Steven A Shallcross's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven A Shallcross within 3 months outperforms 1 times out of 8 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Steven A Shallcross's insider trading performs compared to the benchmark.
Performance of Steven A Shallcross
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 19.78 | | | | | |
| Relative Return to S&P 500(%) | 18.77 | | | | | |
Steven A Shallcross Ownership Network
Steven A Shallcross Owned Company Details
What does Elys Bmg Group Inc do?
Who are the key executives at Elys Bmg Group Inc?
Steven A Shallcross is the director of Elys Bmg Group Inc. Other key executives at Elys Bmg Group Inc include 10 percent owner Gold Street Capital Corp. , director & 10 percent owner & Chief Executive Officer Michael Ciavarella , and Interim CFO Carlo Reali .
Elys Bmg Group Inc (ELYS) Insider Trades Summary
Over the past 18 months, Steven A Shallcross made no insider transaction in Elys Bmg Group Inc (ELYS). Other recent insider transactions involving Elys Bmg Group Inc (ELYS) include a net purchase of 3,322,915 shares made by Gold Street Capital Corp. , and a net purchase of 1,942,345 shares made by Michael Ciavarella .
In summary, during the past 3 months, insiders sold 0 shares of Elys Bmg Group Inc (ELYS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Elys Bmg Group Inc (ELYS) were sold and 5,265,260 shares were bought by its insiders, resulting in a net purchase of 5,265,260 shares.
Elys Bmg Group Inc (ELYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Elys Bmg Group Inc Insider Transactions
Steven A Shallcross Mailing Address
Above is the net worth, insider trading, and ownership report for Steven A Shallcross. You might contact Steven A Shallcross via mailing address: C/o Elys Game Technology Corp., 130 Adelaide Street West, Suite 701, Toronto A6 M5h2k4.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
